DBV Technologies (DBVT) Share-based Compensation (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.54% |
| Dec 31, 2025 | 272.87% |
| Sep 30, 2025 | -58.62% |
| Jun 30, 2025 | -26.65% |
| Mar 31, 2025 | 475.28% |
| Dec 31, 2024 | -128.49% |
| Sep 30, 2024 | 4.26% |
| Jun 30, 2024 | -22.11% |
| Mar 31, 2024 | 60.62% |
| Dec 31, 2023 | -9.97% |
| Sep 30, 2023 | -25.36% |
| Jun 30, 2023 | 11.15% |
| Mar 31, 2023 | 1.37% |
| Dec 31, 2022 | 65.13% |
| Sep 30, 2022 | -9.55% |
| Jun 30, 2022 | -20.91% |
| Mar 31, 2022 | 242.57% |
| Dec 31, 2021 | -161.64% |
| Sep 30, 2021 | 41.77% |
| Jun 30, 2021 | -23.66% |
| Mar 31, 2021 | -21.91% |
| Dec 31, 2020 | 2,579.73% |
| Sep 30, 2020 | 98.76% |
| Jun 30, 2020 | -294.08% |